Differential genomic profiling of progesterone receptor (PR) negative, estrogen receptor (ER) positive HER2-negative metastatic breast cancer (MBC) through circulating tumor DNA

被引：0
|
作者：
Gerratana, Lorenzo
Davis, Andrew
Medford, Arielle
Reduzzi, Carolina
Clifton, Katherine
Podany, Emily
Hensing, Whitney
Velimirovic, Marko
Shah, Ami N.
Foffano, Lorenzo
Arcos, Laura Munoz
Nicolo, Eleonora
Dai, Charles S.
Keenan, Jennifer
Behdad, Amir
Wander, Seth
Gradishar, William
Ma, Cynthia
Puglisi, Fabio
Bardia, Aditya
Cristofanilli, Massimo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-15-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-15-04
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Characteristics of circulating tumor DNA (ctDNA) in patients with ER-positive (ER1), HER2-negative (HER2-) metastatic breast cancer (MBC) on different lines of endocrine treatment
    Bos, M. K.
    Kruger, D. T.
    Jansen, M. P. H. M.
    Martens, J. W. M.
    Boven, E.
    Sleijfer, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
    Chansub Park
    Kyeongmee Park
    Jiyoung Kim
    Youngjoo Sin
    Inseok Park
    Hyunjin Cho
    Keunho Yang
    Byung Noe Bae
    Ki Whan Kim
    Sookyung Ahn
    Geumhee Gwak
    World Journal of Surgical Oncology, 14
  • [23] Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
    Park, Chansub
    Park, Kyeongmee
    Kim, Jiyoung
    Sin, Youngjoo
    Park, Inseok
    Cho, Hyunjin
    Yang, Keunho
    Bae, Byung Noe
    Kim, Ki Whan
    Ahn, Sookyung
    Gwak, Geumhee
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [24] Clinical Importance of estrogen reactivity in Hormone Receptor Positive HER2-Negative Breast Cancer
    Takeshita, Takashi
    Iwase, Hirotaka
    Takabe, Kazuaki
    CANCER SCIENCE, 2023, 114 : 597 - 597
  • [25] Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
    Chan, Melissa
    Chang, Martin C.
    Gonzalez, Rosa
    Lategan, Belinda
    del Barco, Elvira
    Vera-Badillo, Francisco
    Quesada, Paula
    Goldstein, Robyn
    Cruz, Ignacio
    Ocana, Alberto
    Cruz, Juan J.
    Amir, Eitan
    PLOS ONE, 2015, 10 (07):
  • [26] AGGRESSIVE CHEMOTHERAPY FOR ESTROGEN-RECEPTOR (ER) NEGATIVE METASTATIC BREAST-CANCER (MBC)
    LIVINGSTON, R
    FABIAN, C
    RIVKIN, S
    VAUGHN, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 142 - 142
  • [27] The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients
    Reinert, Tomas
    do Rego, Fernanda Orpinelli
    Silva, Matheus Costa e
    Rodrigues, Amanda Muniz
    Koyama, Fernanda Christtanini
    Goncalves, Aline Coelho
    Pauletto, Maiane Maria
    de Carvalho Oliveira, Leandro Jonata
    de Resende, Cristiano Augusto Andrade
    Landeiro, Luciana Castro Garcia
    Barrios, Carlos Henrique
    Mano, Max Senna
    Dienstmann, Rodrigo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [28] Prognostic Significance of Single Progesterone Receptor Positivity A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
    Fan, Ying
    Ding, Xiaoyan
    Xu, Binghe
    Ma, Fei
    Yuan, Peng
    Wang, Jiayu
    Zhang, Pin
    Li, Qing
    Luo, Yang
    MEDICINE, 2015, 94 (46) : e2066
  • [29] Unraveling the influence of progesterone receptor status on endocrine therapy sensitivity: insight from epigenetic and fragmentomics ctDNA profiling in estrogen receptor positive, HER2 negative metastatic breast cancer (MBC)
    Foffano, Lorenzo
    Molteni, Elisabetta
    Dri, Arianna
    Franzoni, Alessandra
    Cucciniello, Linda
    Da Ros, Lucia
    Buriolla, Silvia
    Bolzonello, Silvia
    Noto, Claudia
    Russo, Stefania
    Spazzapan, Simon
    Nascimbeni, Elena
    Pasto, Brenno
    Targato, Giada
    Della Rossa, Serena
    Bonotto, Marta
    Minisini, Alessandro Marco
    Damante, Giuseppe
    Belletti, Barbara
    Gerratana, Lorenzo
    Puglisi, Fabio
    CANCER RESEARCH, 2024, 84 (09)
  • [30] Estrogen receptor (ER) status and survival outcomes in HER2 positive (+) metastatic breast cancer (mBC).
    DeSouza, Karen
    Zammit, Rosa-Rita
    Haire, Anna
    Sinha, Rajesh
    Simcock, Richard
    Moss, Charlotte Hannah
    Mera, Anca
    Mansi, Janine
    Karapanagiotou, Eleni
    Sawyer, Elinor
    Patel, Gargi Surendra
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345